 | • レポートコード：D0804-10991 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、135ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、希少疾患治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。希少疾患治療薬の種類別市場規模（1‰以上、0.65‰〜1‰、0.1‰以下）、用途別市場規模（病院薬局、専門薬局、小売薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis AG、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Bristol-Myers Squibb Company、Alexion Pharmaceuticals, Inc.、Celgene Corporation、AstraZeneca、Sanofi S.A.、Pfizer, Inc.、Novo Nordisk A/S、Merck & Co., Inc.、Takeda、Eisai Co., Ltd.、Deciphera、Johnson & Johnson、GlaxoSmithKline、Daiichi Sankyo Company Limited、Amgen, Inc.、Biogen, Inc.、Bayer AG、Atara Biotherapeutics、ProQR ・地域別グローバル市場分析 2015年-2020年 ・希少疾患治療薬の北米市場（アメリカ、カナダ、メキシコ） ・希少疾患治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・希少疾患治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・希少疾患治療薬の南米市場（ブラジル、アルゼンチン） ・希少疾患治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：1‰以上、0.65‰〜1‰、0.1‰以下 ・用途別分析：病院薬局、専門薬局、小売薬局、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Rare Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Rare Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Rare Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rare Disease Drug market has been segmented into
Above 1‰
0.65‰～1‰
Below 0.1‰
By Application, Rare Disease Drug has been segmented into:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rare Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Rare Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rare Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Rare Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Rare Disease Drug Market Share Analysis
Rare Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rare Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rare Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Rare Disease Drug are:
Novartis AG
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Alexion Pharmaceuticals, Inc.
Celgene Corporation
AstraZeneca
Sanofi S.A.
Pfizer, Inc.
Novo Nordisk A/S
Merck & Co., Inc.
Takeda
Eisai Co., Ltd.
Deciphera
Johnson & Johnson
GlaxoSmithKline
Daiichi Sankyo Company Limited
Amgen, Inc.
Biogen, Inc.
Bayer AG
Atara Biotherapeutics
ProQR
Among other players domestic and global, Rare Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rare Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rare Disease Drug, with price, sales, revenue and global market share of Rare Disease Drug in 2018 and 2019.
Chapter 3, the Rare Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rare Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Rare Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Rare Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Rare Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rare Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Above 1‰
1.2.3 0.65‰～1‰
1.2.4 Below 0.1‰
1.3 Market Analysis by Application
1.3.1 Overview: Global Rare Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 Overview of Global Rare Disease Drug Market
1.4.1 Global Rare Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis AG SWOT Analysis
2.1.4 Novartis AG Product and Services
2.1.5 Novartis AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly and Company SWOT Analysis
2.2.4 Eli Lilly and Company Product and Services
2.2.5 Eli Lilly and Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.3.4 F. Hoffmann-La Roche Ltd. Product and Services
2.3.5 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb Company SWOT Analysis
2.4.4 Bristol-Myers Squibb Company Product and Services
2.4.5 Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alexion Pharmaceuticals, Inc.
2.5.1 Alexion Pharmaceuticals, Inc. Details
2.5.2 Alexion Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alexion Pharmaceuticals, Inc. SWOT Analysis
2.5.4 Alexion Pharmaceuticals, Inc. Product and Services
2.5.5 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Celgene Corporation SWOT Analysis
2.6.4 Celgene Corporation Product and Services
2.6.5 Celgene Corporation Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AstraZeneca SWOT Analysis
2.7.4 AstraZeneca Product and Services
2.7.5 AstraZeneca Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi S.A.
2.8.1 Sanofi S.A. Details
2.8.2 Sanofi S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi S.A. SWOT Analysis
2.8.4 Sanofi S.A. Product and Services
2.8.5 Sanofi S.A. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer, Inc.
2.9.1 Pfizer, Inc. Details
2.9.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer, Inc. SWOT Analysis
2.9.4 Pfizer, Inc. Product and Services
2.9.5 Pfizer, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novo Nordisk A/S
2.10.1 Novo Nordisk A/S Details
2.10.2 Novo Nordisk A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novo Nordisk A/S SWOT Analysis
2.10.4 Novo Nordisk A/S Product and Services
2.10.5 Novo Nordisk A/S Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck & Co., Inc.
2.11.1 Merck & Co., Inc. Details
2.11.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck & Co., Inc. SWOT Analysis
2.11.4 Merck & Co., Inc. Product and Services
2.11.5 Merck & Co., Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda SWOT Analysis
2.12.4 Takeda Product and Services
2.12.5 Takeda Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Eisai Co., Ltd.
2.13.1 Eisai Co., Ltd. Details
2.13.2 Eisai Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Eisai Co., Ltd. SWOT Analysis
2.13.4 Eisai Co., Ltd. Product and Services
2.13.5 Eisai Co., Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Deciphera
2.14.1 Deciphera Details
2.14.2 Deciphera Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Deciphera SWOT Analysis
2.14.4 Deciphera Product and Services
2.14.5 Deciphera Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Johnson & Johnson
2.15.1 Johnson & Johnson Details
2.15.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Johnson & Johnson SWOT Analysis
2.15.4 Johnson & Johnson Product and Services
2.15.5 Johnson & Johnson Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 GlaxoSmithKline
2.16.1 GlaxoSmithKline Details
2.16.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GlaxoSmithKline SWOT Analysis
2.16.4 GlaxoSmithKline Product and Services
2.16.5 GlaxoSmithKline Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Daiichi Sankyo Company Limited
2.17.1 Daiichi Sankyo Company Limited Details
2.17.2 Daiichi Sankyo Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Daiichi Sankyo Company Limited SWOT Analysis
2.17.4 Daiichi Sankyo Company Limited Product and Services
2.17.5 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Amgen, Inc.
2.18.1 Amgen, Inc. Details
2.18.2 Amgen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Amgen, Inc. SWOT Analysis
2.18.4 Amgen, Inc. Product and Services
2.18.5 Amgen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Biogen, Inc.
2.19.1 Biogen, Inc. Details
2.19.2 Biogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Biogen, Inc. SWOT Analysis
2.19.4 Biogen, Inc. Product and Services
2.19.5 Biogen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Bayer AG
2.20.1 Bayer AG Details
2.20.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Bayer AG SWOT Analysis
2.20.4 Bayer AG Product and Services
2.20.5 Bayer AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Atara Biotherapeutics
2.21.1 Atara Biotherapeutics Details
2.21.2 Atara Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Atara Biotherapeutics SWOT Analysis
2.21.4 Atara Biotherapeutics Product and Services
2.21.5 Atara Biotherapeutics Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.22 ProQR
2.22.1 ProQR Details
2.22.2 ProQR Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 ProQR SWOT Analysis
2.22.4 ProQR Product and Services
2.22.5 ProQR Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Rare Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Rare Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Rare Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Rare Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Rare Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Rare Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Rare Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Rare Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Rare Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Rare Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Rare Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Rare Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Rare Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Rare Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Rare Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Rare Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Rare Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Rare Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Rare Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Rare Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Rare Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Rare Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Rare Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Rare Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Rare Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Rare Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Rare Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Rare Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Rare Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Rare Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Rare Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Rare Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Rare Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Rare Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Rare Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Rare Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Rare Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Rare Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Rare Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Rare Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Rare Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Rare Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Rare Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Rare Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Rare Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Rare Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Rare Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Rare Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Rare Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Rare Disease Drug Price by Type (2015-2020)
11 Global Rare Disease Drug Market Segment by Application
11.1 Global Rare Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Rare Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Rare Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Rare Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Rare Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Rare Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Rare Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Rare Disease Drug Market Forecast (2021-2025)
12.2.4 South America Rare Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Rare Disease Drug Market Forecast (2021-2025)
12.3 Rare Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Rare Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Rare Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Rare Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Rare Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Rare Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Rare Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rare Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rare Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis AG Rare Disease Drug Major Business
Table 9. Novartis AG Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 10. Novartis AG SWOT Analysis
Table 11. Novartis AG Rare Disease Drug Product and Services
Table 12. Novartis AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly and Company Rare Disease Drug Major Business
Table 15. Eli Lilly and Company Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 16. Eli Lilly and Company SWOT Analysis
Table 17. Eli Lilly and Company Rare Disease Drug Product and Services
Table 18. Eli Lilly and Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Ltd. Rare Disease Drug Major Business
Table 21. F. Hoffmann-La Roche Ltd. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 22. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 23. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product and Services
Table 24. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 26. Bristol-Myers Squibb Company Rare Disease Drug Major Business
Table 27. Bristol-Myers Squibb Company Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 28. Bristol-Myers Squibb Company SWOT Analysis
Table 29. Bristol-Myers Squibb Company Rare Disease Drug Product and Services
Table 30. Bristol-Myers Squibb Company Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Alexion Pharmaceuticals, Inc. Rare Disease Drug Major Business
Table 33. Alexion Pharmaceuticals, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 34. Alexion Pharmaceuticals, Inc. SWOT Analysis
Table 35. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product and Services
Table 36. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 38. Celgene Corporation Rare Disease Drug Major Business
Table 39. Celgene Corporation Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 40. Celgene Corporation SWOT Analysis
Table 41. Celgene Corporation Rare Disease Drug Product and Services
Table 42. Celgene Corporation Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 44. AstraZeneca Rare Disease Drug Major Business
Table 45. AstraZeneca Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 46. AstraZeneca SWOT Analysis
Table 47. AstraZeneca Rare Disease Drug Product and Services
Table 48. AstraZeneca Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 50. Sanofi S.A. Rare Disease Drug Major Business
Table 51. Sanofi S.A. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 52. Sanofi S.A. SWOT Analysis
Table 53. Sanofi S.A. Rare Disease Drug Product and Services
Table 54. Sanofi S.A. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer, Inc. Rare Disease Drug Major Business
Table 57. Pfizer, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 58. Pfizer, Inc. SWOT Analysis
Table 59. Pfizer, Inc. Rare Disease Drug Product and Services
Table 60. Pfizer, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk A/S Rare Disease Drug Major Business
Table 63. Novo Nordisk A/S Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 64. Novo Nordisk A/S SWOT Analysis
Table 65. Novo Nordisk A/S Rare Disease Drug Product and Services
Table 66. Novo Nordisk A/S Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Merck & Co., Inc. Rare Disease Drug Major Business
Table 69. Merck & Co., Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 70. Merck & Co., Inc. SWOT Analysis
Table 71. Merck & Co., Inc. Rare Disease Drug Product and Services
Table 72. Merck & Co., Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Takeda Basic Information, Manufacturing Base and Competitors
Table 74. Takeda Rare Disease Drug Major Business
Table 75. Takeda Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 76. Takeda SWOT Analysis
Table 77. Takeda Rare Disease Drug Product and Services
Table 78. Takeda Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Eisai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Eisai Co., Ltd. Rare Disease Drug Major Business
Table 81. Eisai Co., Ltd. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 82. Eisai Co., Ltd. SWOT Analysis
Table 83. Eisai Co., Ltd. Rare Disease Drug Product and Services
Table 84. Eisai Co., Ltd. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Deciphera Basic Information, Manufacturing Base and Competitors
Table 86. Deciphera Rare Disease Drug Major Business
Table 87. Deciphera Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 88. Deciphera SWOT Analysis
Table 89. Deciphera Rare Disease Drug Product and Services
Table 90. Deciphera Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Rare Disease Drug Major Business
Table 93. Johnson & Johnson Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 94. Johnson & Johnson SWOT Analysis
Table 95. Johnson & Johnson Rare Disease Drug Product and Services
Table 96. Johnson & Johnson Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 98. GlaxoSmithKline Rare Disease Drug Major Business
Table 99. GlaxoSmithKline Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 100. GlaxoSmithKline SWOT Analysis
Table 101. GlaxoSmithKline Rare Disease Drug Product and Services
Table 102. GlaxoSmithKline Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Daiichi Sankyo Company Limited Basic Information, Manufacturing Base and Competitors
Table 104. Daiichi Sankyo Company Limited Rare Disease Drug Major Business
Table 105. Daiichi Sankyo Company Limited Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 106. Daiichi Sankyo Company Limited SWOT Analysis
Table 107. Daiichi Sankyo Company Limited Rare Disease Drug Product and Services
Table 108. Daiichi Sankyo Company Limited Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Amgen, Inc. Rare Disease Drug Type and Application
Table 110. Amgen, Inc. Rare Disease Drug Major Business
Table 111. Amgen, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 112. Amgen, Inc. SWOT Analysis
Table 113. Amgen, Inc. Rare Disease Drug Product and Services
Table 114. Amgen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Biogen, Inc. Rare Disease Drug Major Business
Table 117. Biogen, Inc. Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 118. Biogen, Inc. SWOT Analysis
Table 119. Biogen, Inc. Rare Disease Drug Product and Services
Table 120. Biogen, Inc. Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 122. Bayer AG Rare Disease Drug Major Business
Table 123. Bayer AG Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 124. Bayer AG SWOT Analysis
Table 125. Bayer AG Rare Disease Drug Product and Services
Table 126. Bayer AG Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Atara Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 128. Atara Biotherapeutics Rare Disease Drug Major Business
Table 129. Atara Biotherapeutics Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 130. Atara Biotherapeutics SWOT Analysis
Table 131. Atara Biotherapeutics Rare Disease Drug Product and Services
Table 132. Atara Biotherapeutics Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. ProQR Basic Information, Manufacturing Base and Competitors
Table 134. ProQR Rare Disease Drug Major Business
Table 135. ProQR Rare Disease Drug Total Revenue (USD Million) (2018-2019)
Table 136. ProQR SWOT Analysis
Table 137. ProQR Rare Disease Drug Product and Services
Table 138. ProQR Rare Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 139. Global Rare Disease Drug Sales by Manufacturer (2018-2019) (K Doses)
Table 140. Global Rare Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 141. Global Rare Disease Drug Sales by Regions (2015-2020) (K Doses)
Table 142. Global Rare Disease Drug Sales Market Share by Regions (2015-2020)
Table 143. Global Rare Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 144. North America Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 145. North America Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 146. North America Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 147. North America Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 148. Europe Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 149. Europe Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 150. Europe Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 151. Asia-Pacific Rare Disease Drug Sales by Regions (2015-2020) (K Doses)
Table 152. Asia-Pacific Rare Disease Drug Sales Market Share by Regions (2015-2020)
Table 153. Asia-Pacific Rare Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 154. South America Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 155. South America Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 156. South America Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 157. South America Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 158. Middle East & Africa Rare Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 159. Middle East & Africa Rare Disease Drug Sales Market Share by Countries (2015-2020)
Table 160. Middle East & Africa Rare Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 161. Middle East & Africa Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Table 162. Global Rare Disease Drug Sales by Type (2015-2020) (K Doses)
Table 163. Global Rare Disease Drug Sales Share by Type (2015-2020)
Table 164. Global Rare Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 165. Global Rare Disease Drug Revenue Share by Type (2015-2020)
Table 166. Global Rare Disease Drug Sales by Application (2015-2020) (K Doses)
Table 167. Global Rare Disease Drug Sales Share by Application (2015-2020)
Table 168. Global Rare Disease Drug Sales Forecast by Regions (2021-2025) (K Doses)
Table 169. Global Rare Disease Drug Market Share Forecast by Regions (2021-2025)
Table 170. Global Rare Disease Drug Sales Forecast by Type (2021-2025) (K Doses)
Table 171. Global Rare Disease Drug Market Share Forecast by Type (2021-2025)
Table 172. Global Rare Disease Drug Sales Forecast by Application (2021-2025)
Table 173. Global Rare Disease Drug Market Share Forecast by Application (2021-2025)
Table 174. Direct Channel Pros & Cons
Table 175. Indirect Channel Pros & Cons
Table 176. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Rare Disease Drug Picture
Figure 2. Global Sales Market Share of Rare Disease Drug by Type in 2019
Figure 3. Above 1‰ Picture
Figure 4. 0.65‰～1‰ Picture
Figure 5. Below 0.1‰ Picture
Figure 6. Rare Disease Drug Sales Market Share by Application in 2018
Figure 7. Hospital Pharmacies Picture
Figure 8. Speciality Pharmacies Picture
Figure 9. Retail pharmacies Picture
Figure 10. Others Picture
Figure 11. Global Rare Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Rare Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Rare Disease Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Rare Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Rare Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Rare Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 37. Global Rare Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Rare Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Rare Disease Drug Revenue Market Share by Regions in 2018
Figure 40. North America Rare Disease Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Rare Disease Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Rare Disease Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Rare Disease Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Rare Disease Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Rare Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Rare Disease Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Rare Disease Drug Sales Market Share by Countries in 2018
Figure 48. North America Rare Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Rare Disease Drug Revenue Market Share by Countries in 2018
Figure 50. United States Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Canada Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Mexico Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 53. Europe Rare Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Rare Disease Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. UK Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. France Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Russia Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Italy Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. Asia-Pacific Rare Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Rare Disease Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Rare Disease Drug Revenue Market Share by Regions 2019
Figure 64. China Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Japan Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Korea Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. India Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. Southeast Asia Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. South America Rare Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Rare Disease Drug Sales Market Share by Countries in 2019
Figure 71. South America Rare Disease Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Argentina Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 74. Middle East and Africa Rare Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Rare Disease Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Rare Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Rare Disease Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Egypt Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Turkey Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. South Africa Rare Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. Global Rare Disease Drug Sales and Growth Rate (2021-2025) (K Doses)
Figure 83. Global Rare Disease Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Rare Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 85. Europe Sales Rare Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 86. Asia-Pacific Sales Rare Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 87. South America Sales Rare Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 88. Middle East & Africa Sales Rare Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
自己免疫疾患治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Autoimmune Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 反毒素の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-Venom market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 991.8 million by 2025, from USD 898.9 million in 2019. The Anti-Venom market report pr…
- 反毒素の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-Venom market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 991.8 million by 2025, from USD 898.9 million in 2019. The Anti-Venom market report pr…
- 小児呼吸器疾患治療の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Pediatric Respiratory Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- デント病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Dent Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…